Evidence map›Paper›PMID 39075726›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

START: A Versatile Platform for Bacterial Ligand Sensing with Programmable Performances.

Jeongwon Kim, Minchae Seo, Yelin Lim, Jongmin Kim

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. START: A Versatile Platform for Bacterial Ligand Sensing with Programmable Performances.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeongwon KimDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Minchae SeoDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Yelin LimDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Jongmin KimDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, South Korea.ORCID 0000-0002-2713-1006

Funding

Gyeongsangbukdo and Pohang city GBTP2023129001Korea Health Industry Development Institute RS-2023-00304637Leaders in INdustry-university Cooperation 3.0Ministry of Education 2021R1A6C101A390National Research Foundation of Korea NRF-2021R1A6A1A10042944National Research Foundation of Korea NRF-2022R1F1A1066642
6 · The paper itself

Abstract

Recognition of signaling molecules for coordinated regulation of target genes is a fundamental process for biological systems. Cells often rely on transcription factors to accomplish these intricate tasks, yet the subtle conformational changes of protein structures, coupled with the complexity of intertwined protein interaction networks, pose challenges for repurposing these for bioengineering applications. This study introduces a novel platform for ligand-responsive gene regulation, termed START (Synthetic Trans-Acting Riboswitch with Triggering RNA). Inspired by the bacterial ligand sensing system, riboswitch, and the synthetic gene regulator, toehold switch, the START platform enables the implementation of synthetic biosensors for various ligands. Rational sequence design with targeted domain optimization yields high-performance STARTs with a dynamic range up to 67.29-fold and a tunable ligand sensitivity, providing a simple and intuitive strategy for sensor engineering. The START platform also exhibits modularity and composability to allow flexible genetic circuit construction, enabling seamless implementation of OR, AND, and NOT Boolean logic gates for multiple ligand inputs. The START design principle is capable of broadening the suite of synthetic biosensors for diverse chemical and protein ligands, providing a novel riboregulator chassis for synthetic biology and bioengineering applications.

Indexed as

Biosensing TechniquesRiboswitchBacteriaGene Expression Regulation, BacterialLigandsSynthetic BiologyLigandsRiboswitchaptamersbiosensorsgenetic circuit constructionriboswitchessynthetic riboregulators

Identifiers

PMID39075726
PMCPMC11423158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.